about
Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation.Healthcare reform in the United States and China: pharmaceutical market implicationsThe political economy of healthcare reform in China: negotiating public and private.Obstacles and opportunities in Chinese pharmaceutical innovation.Animal Research, the 3Rs, and the "Internet of Things": Opportunities and Oversight in International Pharmaceutical Development.Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s).Market watch: Evolution of Chinese bioclusters as a framework for investment policies in emerging markets.
P2860
Q30390211-7D92ECAB-3597-4940-B3DD-7F5462C57AA4Q33984685-9F118A9A-65B4-46DE-8DFD-287DEBFBDF08Q34372441-5F5281C1-CB7A-42B6-9C66-163962939E23Q37720874-DC7D20C5-C552-4093-82BB-EBC3EA47D08EQ39039963-275A1BFC-D1A3-4DA2-9743-E18B40DFA200Q40206138-B41A86B5-44B2-476E-A5CE-4EE390FD8F17Q47577409-B3422CBD-78D7-4CDF-9AB1-868D652479DF
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Life sciences venture capital in emerging markets.
@en
Life sciences venture capital in emerging markets.
@nl
type
label
Life sciences venture capital in emerging markets.
@en
Life sciences venture capital in emerging markets.
@nl
prefLabel
Life sciences venture capital in emerging markets.
@en
Life sciences venture capital in emerging markets.
@nl
P2093
P2860
P356
P1433
P1476
Life sciences venture capital in emerging markets.
@en
P2093
Ajay Agrawal
Justin Chakma
Stephen M Sammut
P2860
P2888
P304
P356
10.1038/NBT.2529
P577
2013-03-01T00:00:00Z